Last Price
948.00
Today's Change
-62.00 (6.13%)
Day's Change
800.00 - 1,040.00
Trading Volume
57,694
Overview
Market Cap
50 Million
Shares Outstanding
5 Million
Avg Volume
124,273
Avg Price (50 Days)
1040.61
Avg Price (200 Days)
411.03
PE Ratio
-4.10
EPS
-2.31
Earnings Announcement
25-Sep-2025
Previous Close
1010.00
Open
1040.00
Day's Range
800.0 - 1040.0
Year Range
124.0 - 1800.0
Trading Volume
57,694
Price Change Highlight
1 Day Change
-6.14%
5 Day Change
23.12%
1 Month Change
-16.84%
3 Month Change
548.21%
6 Month Change
422.31%
Ytd Change
126.20%
1 Year Change
104.31%
3 Year Change
82.31%
5 Year Change
-72.12%
10 Year Change
-99.83%
Max Change
-99.83%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.
Discussions
Be the first to like this.
Showing 0 of 0 comments
Post a Comment
Latest Videos
![[New IPO] Insights Analytics Berhad, a provider of automated test and intelligent asset management solutions for the E&E and water management sectors, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1300/Thumbnail__(8).png)
Apps
Top Articles
1
Stumbling and Mumbling
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
{uid}
{comment}
Just now